Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol

SIMPLE SUMMARY: Sarcomas are a rare group of heterogeneous tumors. Because treatment side-effects detract from the survival benefit of treatment, it is important to assess treatment effectiveness in terms of patient-reported health-related quality of life (HRQoL). However, a sarcoma specific measure...

Descripción completa

Detalles Bibliográficos
Autores principales: den Hollander, Dide, Fiore, Marco, Martin-Broto, Javier, Kasper, Bernd, Casado Herraez, Antonio, Kulis, Dagmara, Nixon, Ioanna, Sodergren, Samantha C., Eichler, Martin, van Houdt, Winan J., Desar, Ingrid M. E., Ray-Coquard, Isabelle, Piccinin, Claire, Kosela-Paterczyk, Hanna, Miah, Aisha, Hentschel, Leopold, Singer, Susanne, Wilson, Roger, van der Graaf, Winette T. A., Husson, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792589/
https://www.ncbi.nlm.nih.gov/pubmed/33561018
http://dx.doi.org/10.3390/cancers13010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792589/
https://www.ncbi.nlm.nih.gov/pubmed/33561018
http://dx.doi.org/10.3390/cancers13010001

Ejemplares similares